Turning Point Therapeutics’ CEO to Present at UBS Healthcare Conference

    NEXT STORY
    Cytori Reports Q1 2019 Business and Financial Results
    PREV STORY
    Altimmune Announces First Quarter 2019 Financial Results and Provides a Business Update
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Baudax Bio Announces Presentation of New Phase IIIb ANJESO™ Data at Digestive Disease Week 2020

    author_avatar
    NASDAQ Market News

    OPKO Health’s 4Kscore® Test Highlighted in Podium Presentation at 112th American Urological Association Annual Meeting

    MIAMI, May 18, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK), announces that data ...

    author_avatar
    NASDAQ Market News

    Sabin Vaccine Institute Receives $20.5 Million From BARDA With Potential of up to $128 Million to Develop Ebola Sudan and Marburg Vaccines

    author_avatar
    NASDAQ Market News